FMED ETF
Fidelity Disruptive Medicine ETF
FMED ETF Overview
FMED ETF (Fidelity Disruptive Medicine ETF) is managed by Fidelity Investments (US) with $45.5M in net assets. FMED expense ratio is 0.50%, holding 77 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2023-02-13.
FMED performance shows a YTD return of 3.98%. The 1-year return is 18.13% and the 5-year return is -1.62%.
FMED top holdings include 10x Genomics Inc Com Usd 1 Cl A (5.1%), Thermo Fisherscientific Inc. (3.9%), Danaher Corporation (3.8%), Natera Inc (3.4%), Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (3.2%). Go to all FMED holdings, FMED sectors, or FMED dividends.
FMED can be compared against other funds. Use FMED overlap to find shared positions, or FMED vs another fund for a side-by-side view. FMED alternatives are available via the screener, along with tax-loss harvesting opportunities.